Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Fabry Disease
Related studies linked through entity extraction aliases.
Canadian Fabry Disease Initiative (CFDI) National Registry
- Status
- RECRUITING
- Phase
- N/A
The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
- Status
- COMPLETED
- Phase
- N/A
Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE1
Antiproteinuric Agents and Fabry Disease
- Status
- COMPLETED
- Phase
- N/A
A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.
- Status
- WITHDRAWN
- Phase
- PHASE4
A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.
- Status
- COMPLETED
- Phase
- N/A
Study of the Effects of Fabrazyme Treatment on Lactation and Infants
- Status
- TERMINATED
- Phase
- PHASE4
A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
Fabry Disease Registry & Pregnancy Sub-registry
- Status
- RECRUITING
- Phase
- N/A
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE2
Neuropathic Pain and Fabry Disease
- Status
- COMPLETED
- Phase
- N/A
Enzyme Replacement Therapy in Fabry Disease
- Status
- TERMINATED
- Phase
- N/A
A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE4
Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
- Status
- COMPLETED
- Phase
- N/A
Replagal Enzyme Replacement Therapy for Adults With Fabry Disease
- Status
- COMPLETED
- Phase
- PHASE4